Find Out How Aurora Cannabis Inc. (ACB) Insiders Are Trading Their Stock?


As of Wednesday close, Aurora Cannabis Inc.’s (NASDAQ:ACB) stock was up $0.02, moving up 1.53 percent to $1.33. The average number of shares traded per day over the past five days has been 8,570,320 shares. 1 time new highs have been achieved over the past 5 days, with a -$0.1200 fall in that time frame. In the last twenty days, the average volume was 13,798,990, while in the previous 50 days, it was 12,838,102.

Since last month, ACB stock rose 7.26%. Shares of the company fell to $1.0300 on 10/24/22, the lowest level in the past month. A 52-week high of $6.94 was reached on 01/11/22 after having rallying from a 52-week low of $0.98. Since the beginning of this year, ACB’s stock price has dropped by -75.42% or -$4.0800, and marked a new high 2 times. However, the stock has declined by -80.84% since its 52-week high.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


Valuation Metrics

The stock’s beta is 3.01. Besides these, the trailing price-to-sales (P/S) ratio of 2.93, the price-to-book (PB) ratio of 0.72.

Financial Health

In the three months ended June 29, Aurora Cannabis Inc.’s quick ratio stood at 2.90, while its current ratio was 3.70, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.51, and the total debt-to-equity ratio was 0.59. On the profitability front, the trailing twelve-month gross margin is -63.80% percent. Based on annual data, ACB earned $16.77 million in gross profit and brought in $174.88 million in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -183.60%. Return on equity (ROE) for the past 12 months was -164.90%.

According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. While analysts expected Aurora Cannabis Inc. to report -$0.15 quarterly earnings, the actual figure was $0 per share. During the quarter, the company generated -$33.61 million in EBITDA. The liabilities of Aurora Cannabis Inc. were 440.89 million at the end of its most recent quarter ended June 29, and its total debt was $269.49 million.

Technical Picture

This quick technical analysis looks at Aurora Cannabis Inc.’s (ACB) price momentum. With a historical volatility rate of 99.54%, the RSI 9-day stood at 47.90% on 23 November.

With respect to its five-day moving average, the current Aurora Cannabis Inc. price is down by -8.28% percent or -$0.1200. At present, ACB shares trade +5.56% above its 20-day simple moving average and -2.21% percent below its 100-day simple moving average. However, the stock is currently trading approximately -13.07% below its SMA50 and -68.11% below its SMA200.

Stochastic coefficient K was 31.82% and Stochastic coefficient D was 36.36%, while ATR was 0.1225. Given the Stochastic reading of 34.09% for the 14-day period, the RSI (14) reading has been calculated as 49.97%. As of today, the MACD Oscillator reading stands at -0.0989, while the 14-day reading stands at -0.0550.

Analyst Ratings

Canaccord Genuity upgraded its rating on Aurora Cannabis Inc. (NASDAQ: ACB) to a Hold in a note to investors on September 21, 2022. The analysts firm previously had a Sell rating on the stock.Aurora Cannabis Inc. (ACB) has been rated Hold by analysts. According to 0 brokerage firms, ACB is a sell, and 10 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 1 analyst rate Aurora Cannabis Inc. stock as buy, with 1 recommending it as overweight.

With a median target price of $1.51, the current consensus forecast for the stock is $1.32 – $2.26. Based on these forecasts, analysts predict Aurora Cannabis Inc. (ACB) will achieve an average price target of $1.61.


Please enter your comment!
Please enter your name here